| Name | sulfiredoxin 1 |
| Description | Enables oxidoreductase activity, acting on a sulfur group of donors. Involved in response to oxidative stress. Located in cytosol. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSulfiredoxin 1 (SRXN1) is an evolutionarily conserved redox‐regulatory enzyme that plays a central role in restoring the function of antioxidant proteins during oxidative stress. By catalyzing the ATP‐dependent reduction of hyperoxidized cysteine sulfinic acid in typical 2-Cys peroxiredoxins, SRXN1 regenerates their peroxidase activity and thus maintains cellular redox homeostasis. In addition, SRXN1 participates in deglutathionylation reactions that reverse glutathione adducts on critical proteins, restoring enzyme activities and further contributing to the regulation of redox‐mediated signal transduction. These mechanistic insights, together with detailed structural analyses that reveal its unique nucleotide binding and catalytic motifs, underscore the enzyme’s multifaceted role in protecting cells against oxidative and nitrosative stress."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn diverse disease contexts, particularly in cancer and other oxidative stress-related pathologies, aberrant SRXN1 expression has been implicated in modulating cellular responses and tumor behavior. SRXN1 is under transcriptional control of the NRF2 pathway and is upregulated in conditions such as lung injury, fibrotic lung diseases, and various malignancies. In these settings, elevated SRXN1 expression not only counteracts oxidative damage but also influences key signaling cascades – including AP-1, MAPK, and EGFR pathways – which promote cell survival, migration, and invasion. Its modulation has been directly associated with changes in epithelial-mesenchymal transition markers, implicating SRXN1 in the progression and metastasis of tumors, as well as in resistance to chemoradiotherapy."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "26"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFurthermore, emerging evidence indicates that SRXN1 not only serves as a guardian against oxidative stress but also acts as a pro-tumorigenic factor in a range of cancers, including colorectal, hepatocellular, esophageal squamous cell, cervical, and prostate carcinomas. In these studies, high SRXN1 levels have been correlated with enhanced cell proliferation, invasion, and metastatic potential, as well as with poor patient prognosis. Moreover, the enzyme has been linked to therapeutic resistance, suggesting that its inhibition might synergize with current treatments by disrupting ROS-mediated survival signals. Collectively, these findings highlight SRXN1 as a promising prognostic biomarker and a potential target for therapeutic intervention in malignancies driven by redox imbalances."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "27", "end_ref": "32"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Thomas J Jönsson, Michael S Murray, Lynnette C Johnson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural basis for the retroreduction of inactivated peroxiredoxins by human sulfiredoxin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi050131i"}], "href": "https://doi.org/10.1021/bi050131i"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15952770"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15952770"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Woojin Jeong, Sung Jun Park, Tong-Shin Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M511082200"}], "href": "https://doi.org/10.1074/jbc.M511082200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16565085"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16565085"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Victoria J Findlay, Danyelle M Townsend, Taylor E Morris, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel role for human sulfiredoxin in the reversal of glutathionylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-06-0484"}], "href": "https://doi.org/10.1158/0008-5472.CAN-06-0484"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16818657"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16818657"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Duck-Yeon Lee, Sung Jun Park, Woojin Jeong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutagenesis and modeling of the peroxiredoxin (Prx) complex with the NMR structure of ATP-bound human sulfiredoxin implicate aspartate 187 of Prx I as the catalytic residue in ATP hydrolysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi061824h"}], "href": "https://doi.org/10.1021/bi061824h"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17176052"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17176052"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Thomas J Jönsson, Lynnette C Johnson, W Todd Lowther "}, {"type": "b", "children": [{"type": "t", "text": "Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature06415"}], "href": "https://doi.org/10.1038/nature06415"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18172504"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18172504"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Thomas J Jönsson, Michael S Murray, Lynnette C Johnson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M803244200"}], "href": "https://doi.org/10.1074/jbc.M803244200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18579529"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18579529"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Thomas J Jönsson, Allen W Tsang, W Todd Lowther, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.C800124200"}], "href": "https://doi.org/10.1074/jbc.C800124200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18593714"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18593714"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Anju Singh, Guoyu Ling, Avvaru N Suhasini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2008.10.026"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2008.10.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19027064"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19027064"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Qiou Wei, Hong Jiang, Connie P Matthews, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0810676105"}], "href": "https://doi.org/10.1073/pnas.0810676105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19057013"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19057013"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Ji Won Park, John J Mieyal, Sue Goo Rhee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.021394"}], "href": "https://doi.org/10.1074/jbc.M109.021394"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19561357"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19561357"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Thomas J Jönsson, Lynnette C Johnson, W Todd Lowther "}, {"type": "b", "children": [{"type": "t", "text": "Protein engineering of the quaternary sulfiredoxin.peroxiredoxin enzyme.substrate complex reveals the molecular basis for cysteine sulfinic acid phosphorylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.036400"}], "href": "https://doi.org/10.1074/jbc.M109.036400"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19812042"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19812042"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Witold Mazur, Pamela Lindholm, Kirsi Vuorinen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "APMIS (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1600-0463.2010.02646.x"}], "href": "https://doi.org/10.1111/j.1600-0463.2010.02646.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20718723"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20718723"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Qiou Wei, Hong Jiang, Zhen Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1013012108"}], "href": "https://doi.org/10.1073/pnas.1013012108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21487000"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21487000"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Heta Merikallio, Paavo Pääkkö, Vuokko L Kinnula, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2011.05.024"}], "href": "https://doi.org/10.1016/j.humpath.2011.05.024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21943684"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21943684"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Jin Young Baek, Sun Hee Han, Su Haeng Sung, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfiredoxin protein is critical for redox balance and survival of cells exposed to low steady-state levels of H2O2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.316711"}], "href": "https://doi.org/10.1074/jbc.M111.316711"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22086924"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22086924"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Malabendu Jana, Susanta Mondal, Frank J Gonzalez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-β."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.398552"}], "href": "https://doi.org/10.1074/jbc.M112.398552"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22879602"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22879602"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Robert R Bowers, Yefim Manevich, Danyelle M Townsend, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfiredoxin redox-sensitive interaction with S100A4 and non-muscle myosin IIA regulates cancer cell motility."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi301006w"}], "href": "https://doi.org/10.1021/bi301006w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22934964"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22934964"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jaana M Hartikainen, Maria Tengström, Veli-Matti Kosma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-12-1474"}], "href": "https://doi.org/10.1158/0008-5472.CAN-12-1474"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22964583"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22964583"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Murli Mishra, Hong Jiang, Lisha Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2015.07.002"}], "href": "https://doi.org/10.1016/j.canlet.2015.07.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26170166"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26170166"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Hong Jiang, Lisha Wu, Jing Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfiredoxin Promotes Colorectal Cancer Cell Invasion and Metastasis through a Novel Mechanism of Enhancing EGFR Signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-15-0240"}], "href": "https://doi.org/10.1158/1541-7786.MCR-15-0240"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26290602"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26290602"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Stefano Turolo, Alberto Edefonti, Marta Lepore, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SXR rs3842689: a prognostic factor for steroid sensitivity or resistance in pediatric idiopathic nephrotic syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/pgs-2016-0029"}], "href": "https://doi.org/10.2217/pgs-2016-0029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27377607"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27377607"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Carmen R Sunico, Abdullah Sultan, Tomohiro Nakamura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of sulfiredoxin as a peroxiredoxin-2 denitrosylase in human iPSC-derived dopaminergic neurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1608784113"}], "href": "https://doi.org/10.1073/pnas.1608784113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27821734"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27821734"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Sa Shi, Yunqiu Guo, Yanping Lou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfiredoxin involved in the protection of peroxiredoxins against hyperoxidation in the early hyperglycaemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2017.02.015"}], "href": "https://doi.org/10.1016/j.yexcr.2017.02.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28202395"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28202395"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Kangyun Lan, Xiaoyan Chen, Qin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Highly expressed sulfiredoxin and β-catenin are associated with malignancy of cervical squamous cell carcinoma]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2017)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28274319"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28274319"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Xiaoyan Chen, Kangyun Lan, Qin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1010428317695942"}], "href": "https://doi.org/10.1177/1010428317695942"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28351308"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28351308"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Kangyun Lan, Yuni Zhao, Yue Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms18050917"}], "href": "https://doi.org/10.3390/ijms18050917"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28448437"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28448437"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Joonas Haapasalo, Kristiina Nordfors, Kirsi J Granberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histol Histopathol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14670/HH-11-973"}], "href": "https://doi.org/10.14670/HH-11-973"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29441509"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29441509"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Qian-Wen Rao, Shi-Long Zhang, Meng-Zhou Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfiredoxin-1 is a promising novel prognostic biomarker for hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.3430"}], "href": "https://doi.org/10.1002/cam4.3430"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32955798"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32955798"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Junwen Luo, Zhongxian Tian, Yongjia Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircABCA13 acts as a miR-4429 sponge to facilitate esophageal squamous cell carcinoma development by stabilizing SRXN1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.15807"}], "href": "https://doi.org/10.1111/cas.15807"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37017121"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37017121"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Xing Wang, Jiandi Yu, Huali Wen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Urol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12894-023-01319-1"}], "href": "https://doi.org/10.1186/s12894-023-01319-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37726767"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37726767"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Jiachun Wei, Di Qiu, Xiaofeng Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Unraveling the role of sulfiredoxin-1 in early-onset preeclampsia: A key player in trophoblast ferroptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Reprod Immunol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jri.2024.104273"}], "href": "https://doi.org/10.1016/j.jri.2024.104273"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38852489"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38852489"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Qianwen Rao, Mengzhou Guo, Jialei Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sulfiredoxin-1 promotes the growth of hepatocellular carcinoma by inhibiting TFEB-mediated autophagy and lysosome biogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2024.114169"}], "href": "https://doi.org/10.1016/j.yexcr.2024.114169"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39029574"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39029574"}]}]}]}
|
| Synonyms | SRX, SRX1, NPN3, C20ORF139 |
| Proteins | SRXN1_HUMAN |
| NCBI Gene ID | 140809 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SRXN1 has 6,598 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 100 datasets.
Click the + buttons to view associations for SRXN1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SRXN1 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SRXN1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SRXN1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of SRXN1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SRXN1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SRXN1 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SRXN1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SRXN1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with SRXN1 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SRXN1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SRXN1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SRXN1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SRXN1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SRXN1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SRXN1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SRXN1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SRXN1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| CORUM Protein Complexes | protein complexs containing SRXN1 protein from the CORUM Protein Complexes dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SRXN1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SRXN1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SRXN1 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SRXN1 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of SRXN1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SRXN1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SRXN1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SRXN1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SRXN1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SRXN1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SRXN1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SRXN1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SRXN1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SRXN1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SRXN1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SRXN1 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SRXN1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SRXN1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SRXN1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SRXN1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SRXN1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SRXN1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SRXN1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SRXN1 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SRXN1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SRXN1 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing SRXN1 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing SRXN1 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SRXN1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SRXN1 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SRXN1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SRXN1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SRXN1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of SRXN1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SRXN1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SRXN1 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for SRXN1 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SRXN1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SRXN1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SRXN1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for SRXN1 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SRXN1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SRXN1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SRXN1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SRXN1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SRXN1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate SRXN1 protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SRXN1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of SRXN1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SRXN1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SRXN1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SRXN1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SRXN1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SRXN1 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SRXN1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SRXN1 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SRXN1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of SRXN1 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SRXN1 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SRXN1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SRXN1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SRXN1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SRXN1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving SRXN1 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SRXN1 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SRXN1 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of SRXN1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SRXN1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SRXN1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SRXN1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SRXN1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with SRXN1 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of SRXN1 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SRXN1 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SRXN1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SRXN1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SRXN1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SRXN1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SRXN1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SRXN1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SRXN1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SRXN1 protein from the WikiPathways Pathways 2024 dataset. | |